Present final non-interventional trial results in HS and AD
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 12 Jan 2021
- Due
- 30 Jun 2021
- Checked
- 24 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Presentation of final Non-Interventional trial results in HS and AD (1H 2021)”
What we found
Evidence strength A What the grades mean
The company did not present the final non-interventional trial results in HS and AD by the 1H 2021 deadline, instead pushing the milestone for patient cohort results to 1H 2022.
-
A Kymera Therapeutics, Inc. 8-K filed 2021-08-06
“Expected Milestones: • Presentation of Phase 1 proof-of-biology in healthy volunteers (4Q21) • Presentation of Phase 1 proof-of-biology in AD and HS patient cohort (1H22)” ✓ confirmed on the page
Market reaction: the shares moved +0.9% against the S&P 500 over the three sessions around the disclosure (5 Aug 2021 to 10 Aug 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Present
- Deliverable
- Non-interventional trial results
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Kymera Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-KYMR-021891 · Corrections policy